Correction: Origin of Cardiomyocytes in the Adult Heart (Circ Res. (2015) 116 (150-166) DOI: 10.1161/CIRCRESAHA.116.303595);Origin of cardiomyocytes in the adult heart

Circulation Research

Volumn 116, Issue 1, 2015, Pages 150-166

  Leri, Annarosa ^a   Rota, Marcello ^a   Pasqualini, Francesco S ^a   Goichberg, Polina ^a   Anversa, Piero ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cell dedifferentiation; cell transdifferentiation; stem cells

Indexed keywords

CARDIAC STEM CELL; CELL CYCLE; CELL DEDIFFERENTIATION; CELL DIVISION; CELL REGENERATION; CELL THERAPY; CELL TRANSDIFFERENTIATION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ADULT; ANIMAL; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; GROWTH, DEVELOPMENT AND AGING; HEART; ORGANOGENESIS; PHYSIOLOGY;

ADULT; ANIMALS; CELL DIFFERENTIATION; HEART; HEMATOPOIETIC STEM CELLS; HUMANS; MYOCYTES, CARDIAC; ORGANOGENESIS;

EID: 84920837941     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0000000000000081     Document Type: Erratum

References (161)

1. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998;83:1-14.
2. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 1998;83:15-26.
3. Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473:326-335. doi:10.1038/nature10147.
4. Braun T, Martire A. Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology. Trends Biotechnol. 2007;25:441-447. doi:10.1016/j.tibtech.2007.08.004.
5. Yi BA, Wernet O, Chien KR. Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest. 2010;120:20-28. doi:10.1172/JCI40820.
6. Lopez LR, Schocket AL, Stanford RE, Claman HN, Kohler PF. Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol. 1980;7:677-684.
7. Maude GH. Bone marrow infarction in sickle cell anemia. Blood. 1984;63:243.
8. Watanabe K, Abe H, Mishima T, Ogura G, Suzuki T. Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schönlein purpura and polyarteritis nodosa. Pathol Int. 2003;53:569-573.
9. Leong FT, Freeman LJ. Acute renal infarction. J R Soc Med. 2005;98:121-122. doi:10.1258/jrsm.98.3.121.
10. Berland T, Oldenburg WA. Acute mesenteric ischemia. Curr Gastroenterol Rep. 2008;10:341-346.
11. Leri A, Kajstura J, Anversa P. Cardiac regeneration and aging. In: Rosenthal N, Harvey RP, eds Heart Development and Regeneration, vol II. London: Elsevier; 2010:951-980.
12. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009;84:876-892. doi:10.1016/S0025-6196(11)60505-3.
13. Beohar N, Rapp J, Pandya S, Losordo DW. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol. 2010;56:1287-1297. doi:10.1016/j. jacc.2010.05.039.
14. Mohsin S, Siddiqi S, Collins B, Sussman MA. Empowering adult stem cells for myocardial regeneration. Circ Res. 2011;109:1415-1428. doi:10.1161/CIRCRESAHA.111.243071.
15. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923-940. doi:10.1161/CIRCRESAHA.111.243147.
16. Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res. 2011;109:941-961. doi:10.1161/CIRCRESAHA.111.243154.
17. Anversa P, Leri A. Innate regeneration in the aging heart: healing from within. Mayo Clin Proc. 2013;88:871-883. doi:10.1016/j. mayocp.2013.04.001.
18. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810-834. doi:10.1161/CIRCRESAHA.113.300219.
19. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest. 2013;123:62-70. doi:10.1172/JCI63068.
20. Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33:2265-2271. doi:10.1093/eurheartj/ehs191.
21. Dorn GW 2nd. Molecular mechanisms that differentiate apoptosis from programmed necrosis. Toxicol Pathol. 2013;41:227-234. doi:10.1177/0192623312466961.
22. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltytė Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E; PEACE Investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61:1240-1249. doi:10.1016/j. jacc.2012.12.026.
23. Wohlschlaeger J, Levkau B, Brockhoff G, Schmitz KJ, von Winterfeld M, Takeda A, Takeda N, Stypmann J, Vahlhaus C, Schmid C, Pomjanski N, Böcking A, Baba HA. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart. Circulation. 2010;121:989-996. doi:10.1161/CIRCULATIONAHA.108.808071.
24. Kajstura J, Urbanek K, Perl S, et al. Cardiomyogenesis in the adult human heart. Circ Res. 2010;107:305-315. doi:10.1161/CIRCRESAHA.110.223024.
25. Quaini F, Cigola E, Lagrasta C, Saccani G, Quaini E, Rossi C, Olivetti G, Anversa P. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res. 1994;75:1050-1063.
26. Beltrami CA, Di Loreto C, Finato N, Rocco M, Artico D, Cigola E, Gambert SR, Olivetti G, Kajstura J, Anversa P. Proliferating cell nuclear antigen (PCNA), DNA synthesis and mitosis in myocytes following cardiac transplantation in man. J Mol Cell Cardiol. 1997;29:2789-2802. doi:10.1006/jmcc.1997.0514.
27. Kajstura J, Gurusamy N, Ogórek B, et al. Myocyte turnover in the aging human heart. Circ Res. 2010;107:1374-1386. doi:10.1161/CIRCRESAHA.110.231498.
28. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 1998;95:8801-8805.
29. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750-1757. doi:10.1056/NEJM200106073442303.
30. Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B, Leri A, Kajstura J, Quaini E, Anversa P. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA. 2003;100:10440-10445. doi:10.1073/pnas.1832855100.
31. Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA. 2005;102:8692-8697. doi:10.1073/pnas.0500169102.
32. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu TD, Guerquin-Kern JL, Lechene CP, Lee RT. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013;493:433-436. doi:10.1038/nature11682.
33. Capasso JM, Bruno S, Cheng W, Li P, Rodgers R, Darzynkiewicz Z, Anversa P. Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats. Circ Res. 1992;71:1379-1389.
34. Gonzalez A, Rota M, Nurzynska D, et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res. 2008;102:597-606. doi:10.1161/CIRCRESAHA.107.165464.
35. Hosoda T, D'Amario D, Cabral-Da-Silva MC, et al. Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci USA. 2009;106:17169-17174. doi:10.1073/pnas.0903089106.
36. Sanada F, Kim J, Czarna A, et al. c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy. Circ Res. 2014;114:41-55. doi:10.1161/CIRCRESAHA.114.302500.
37. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, Cheng W, Darzynkiewicz Z, Olivetti G, Anversa P. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res. 1994;74:383-400.
38. Limana F, Urbanek K, Chimenti S, Quaini F, Leri A, Kajstura J, Nadal-Ginard B, Izumo S, Anversa P. bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA. 2002;99:6257-6262. doi:10.1073/pnas.092672899.
39. Haubner BJ, Adamowicz-Brice M, Khadayate S, Tiefenthaler V, Metzler B, Aitman T, Penninger JM. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging (Albany NY). 2012;4:966-977.
40. Olivetti G, Ricci R, Anversa P. Hyperplasia of myocyte nuclei in longterm cardiac hypertrophy in rats. J Clin Invest. 1987;80:1818-1821. doi:10.1172/JCI113278.
41. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Capasso JM. Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart. J Clin Invest. 1990;85:994-997. doi:10.1172/JCI114576.
42. Force T, Michael A, Kilter H, Haq S. Stretch-activated pathways and left ventricular remodeling. J Card Fail. 2002;8:S351-S358. doi:10.1054/jcaf.2002.129272.
43. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, Robbins J, Lee RT. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007;13:970-974. doi:10.1038/nm1618.
44. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P, Blasco MA. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003;22:131-139. doi:10.1093/emboj/cdg013.
45. Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, Urbanek K, Nadal-Ginard B, Kajstura J, Anversa P, Leri A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004;94:514-524. doi:10.1161/01.RES.0000117306.10142.50.
46. Torzewski M, Wenzel P, Kleinert H, Becker C, El-Masri J, Wiese E, Brandt M, Pautz A, Twardowski L, Schmitt E, Münzel T, Reifenberg K. Chronic inflammatory cardiomyopathy of interferon γ-overexpressing transgenic mice is mediated by tumor necrosis factor-α. Am J Pathol. 2012;180:73-81. doi:10.1016/j.ajpath.2011.09.006.
47. Ellison GM, Vicinanza C, Smith AJ, et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013;154:827-842. doi:10.1016/j.cell.2013.07.039.
48. Sdek P, Zhao P, Wang Y, Huang CJ, Ko CY, Butler PC, Weiss JN, Maclellan WR. Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J Cell Biol. 2011;194:407-423. doi:10.1083/jcb.201012049.
49. Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Rivière AB, Doevendans PA, Field LJ. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res. 2008;78:18-25. doi:10.1093/cvr/cvm101.
50. Bersell K, Arab S, Haring B, Kühn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138:257-270. doi:10.1016/j.cell.2009.04.060.
51. Kühn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, Keating MT. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962-969. doi:10.1038/nm1619.
52. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007;101:313-321. doi:10.1161/CIRCRESAHA.107.149047.
53. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005;19:1175-1187. doi:10.1101/gad.1306705.
54. Engel FB, Schebesta M, Keating MT. Anillin localization defect in cardiomyocyte binucleation. J Mol Cell Cardiol. 2006;41:601-612. doi:10.1016/j.yjmcc.2006.06.012.
55. Shapiro SD, Ranjan AK, Kawase Y, Cheng RK, Kara RJ, Bhattacharya R, Guzman-Martinez G, Sanz J, Garcia MJ, Chaudhry HW. Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes. Sci Transl Med. 2014;6:224ra27. doi:10.1126/scitranslmed.3007668.
56. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, Schneider MD. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest. 1997;100:2722-2728. doi:10.1172/JCI119817.
57. Murnane JP. Telomere dysfunction and chromosome instability. Mutat Res. 2012;730:28-36. doi:10.1016/j.mrfmmm.2011.04.008.
58. Grafi G. How cells dedifferentiate: a lesson from plants. Dev Biol. 2004;268:1-6. doi:10.1016/j.ydbio.2003.12.027.
59. Poss KD. Getting to the heart of regeneration in zebrafish. Semin Cell Dev Biol. 2007;18:36-45. doi:10.1016/j.semcdb.2006.11.009.
60. Kragl M, Knapp D, Nacu E, Khattak S, Maden M, Epperlein HH, Tanaka EM. Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature. 2009;460:60-65. doi:10.1038/nature08152.
61. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol. 2012;57:692-694. doi:10.1016/j.jhep.2012.04.016.
62. Tata PR, Mou H, Pardo-Saganta A, Zhao R, Prabhu M, Law BM, Vinarsky V, Cho JL, Breton S, Sahay A, Medoff BD, Rajagopal J. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature. 2013;503:218-223. doi:10.1038/nature12777.
63. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455:627-632. doi:10.1038/nature07314.
64. Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY, Poss KD. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010;464:601-605. doi:10.1038/nature08804.
65. Kikuchi K, Poss KD. Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol. 2012;28:719-741. doi:10.1146/annurev-cellbio-101011-155739.
66. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078-1080. doi:10.1126/science.1200708.
67. Naqvi N, Li M, Calvert JW, et al. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell. 2014;157:795-807. doi:10.1016/j.cell.2014.03.035.
68. Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allessie M, Borgers M. Time course of atrial fibrillationinduced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol. 2001;33:2083-2094. doi:10.1006/jmcc.2001.1472.
69. Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, Wietelmann A, Tanaka M, Lörchner H, Schimanski S, Szibor M, Warnecke H, Braun T. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell. 2011;9:420-432. doi:10.1016/j. stem.2011.08.013.
70. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705. doi:10.1038/35070587.
71. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA. 2007;104:14068-14073. doi:10.1073/pnas.0706760104.
72. Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogórek B, Rondon-Clavo C, Ferreira-Martins J, Matsuda A, Arranto C, Goichberg P, Giordano G, Haley KJ, Bardelli S, Rayatzadeh H, Liu X, Quaini F, Liao R, Leri A, Perrella MA, Loscalzo J, Anversa P. Evidence for human lung stem cells. N Engl J Med. 2011;364:1795-1806.
73. Elsässer A, Schlepper M, Klövekorn WP, Cai WJ, Zimmermann R, Müller KD, Strasser R, Kostin S, Gagel C, Münkel B, Schaper W, Schaper J. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931.
74. Tomanek RJ, Cooper G 4th. Morphological changes in the mechanically unloaded myocardial cell. Anat Rec. 1981;200:271-280. doi:10.1002/ar.1092000305.
75. Anversa P, Vitali-Mazza L, Loud AV. Morphometric and autoradiographic study of developing ventricular and atrial myocardium in fetal rats. Lab Invest. 1975;33:696-705.
76. Anversa P, Vitali-Mazza L, Gandolfi A, Loud AV. Morphometry and autoradiography of early hypertrophic changes in the ventricular myocardium of adult rat. A light microscopic study. Lab Invest. 1975;33:125-129.
77. Anversa P, Loud AV, Vitali-Mazza L. Morphometry and autoradiography of early hypertrophic changes in the ventricular myocardium of adult rat: an electron microscopic study. Lab Invest. 1976;35:475-483.
78. Zhang Y, Li TS, Lee ST, Wawrowsky KA, Cheng K, Galang G, Malliaras K, Abraham MR, Wang C, Marbán E. Dedifferentiation and proliferation of mammalian cardiomyocytes. PLoS One. 2010;5:e12559. doi:10.1371/journal.pone.0012559.
79. Ferreira-Martins J, Ogórek B, Cappetta D, et al. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res. 2012;110:701-715. doi:10.1161/CIRCRESAHA.111.259507.
80. Leri A, Barlucchi L, Limana F, Deptala A, Darzynkiewicz Z, Hintze TH, Kajstura J, Nadal-Ginard B, Anversa P. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci USA. 2001;98:8626-8631. doi:10.1073/pnas.151013298.
81. Leri A, Kajstura J, Anversa P. Identity deception: not a crime for a stem cell. Physiology (Bethesda). 2005;20:162-168. doi:10.1152/physiol.00005.2005.
82. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med. 2002;346:5-15. doi:10.1056/NEJMoa012081.
83. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98:10344-10349. doi:10.1073/pnas.181177898.
84. Kuramochi Y, Fukazawa R, Migita M, Hayakawa J, Hayashida M, Uchikoba Y, Fukumi D, Shimada T, Ogawa S. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Pediatr Res. 2003;54:319-325. doi:10.1203/01.PDR.0000078275.14079.77.
85. Kajstura J, Rota M, Whang B, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005;96:127-137. doi:10.1161/01.RES.0000151843.79801.60.
86. Lagostena L, Avitabile D, De Falco E, Orlandi A, Grassi F, Iachininoto MG, Ragone G, Fucile S, Pompilio G, Eusebi F, Pesce M, Capogrossi MC. Electrophysiological properties of mouse bone marrow c-kit+ cells co-cultured onto neonatal cardiac myocytes. Cardiovasc Res. 2005;66:482-492. doi:10.1016/j.cardiores.2005.01.018.
87. Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA. 2007;104:17783-17788. doi:10.1073/pnas.0706406104.
88. Li TS, Hayashi M, Ito H, Furutani A, Murata T, Matsuzaki M, Hamano K. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation. 2005;111:2438-2445. doi:10.1161/01. CIR.0000167553.49133.81.
89. Xaymardan M, Cimini M, Fazel S, Weisel RD, Lu WY, Martin U, Harvey RP, Li RK. c-Kit function is necessary for in vitro myogenic differentiation of bone marrow hematopoietic cells. Stem Cells. 2009;27:1911-1920. doi:10.1002/stem.106.
90. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH, Johnson KL, Aikawa R, Asahara T, Losordo DW. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005;115:326-338. doi:10.1172/JCI22326.
91. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, Kearney M, Zak V, Asahara T, Losordo DW. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114:2163-2169. doi:10.1161/CIRCULATIONAHA.106.644518.
92. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto K, Horii M, Matsumoto T, Murasawa S, Shibata T, Suehiro S, Asahara T. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113:1311-1325. doi:10.1161/CIRCULATIONAHA.105.541268.
93. Yoon J, Choi SC, Park CY, Choi JH, Kim YI, Shim WJ, Lim DS. Bone marrow-derived side population cells are capable of functional cardiomyogenic differentiation. Mol Cells. 2008;25:216-223.
94. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010;107:913-922. doi:10.1161/CIRCRESAHA.110.222703.
95. Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H, Houser SR. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res. 2013;113:539-552. doi:10.1161/CIRCRESAHA.113.301202.
96. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668-673. doi:10.1038/nature02460.
97. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664-668. doi:10.1038/nature02446.
98. Jackson KA, Snyder DS, Goodell MA. Skeletal muscle fiber-specific green autofluorescence: potential for stem cell engraftment artifacts. Stem Cells. 2004;22:180-187. doi:10.1634/stemcells.22-2-180.
99. Anversa P, Leri A, Rota M, Hosoda T, Bearzi C, Urbanek K, Kajstura J, Bolli R. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells. 2007;25:589-601. doi:10.1634/stemcells.2006-0623.
100. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011;8:389-398. doi:10.1016/j. stem.2011.02.002.
101. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008;3:1422-1434. doi:10.1038/nprot.2008.138.
102. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-1402. doi:10.1172/JCI12150.
103. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116:1865-1877. doi:10.1172/JCI27019.
104. Fazel SS, Chen L, Angoulvant D, Li SH, Weisel RD, Keating A, Li RK. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J. 2008;22:930-940. doi:10.1096/fj.07-8636com.
105. Theise ND, Krause DS, Sharkis S. Comment on "Little evidence for developmental plasticity of adult hematopoietic stem cells". Science. 2003;299:1317; author reply 1317. doi:10.1126/science.1078412.
106. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
107. Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005;97:663-673. doi:10.1161/01.RES.0000183733.53101.11.
108. Linke A, Müller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, Castaldo C, Cascapera S, Böhm M, Quaini F, Urbanek K, Leri A, Hintze TH, Kajstura J, Anversa P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA. 2005;102:8966-8971. doi:10.1073/pnas.0502678102.
109. D'Amario D, Cabral-Da-Silva MC, Zheng H, et al. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res. 2011;108:1467-1481. doi:10.1161/CIRCRESAHA.111.240648.
110. Kajstura J, Bai Y, Cappetta D, Kim J, Arranto C, Sanada F, D'Amario D, Matsuda A, Bardelli S, Ferreira-Martins J, Hosoda T, Leri A, Rota M, Loscalzo J, Anversa P. Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res. 2012;111:894-906. doi:10.1161/CIRCRESAHA.112.273649.
111. Urbanek K, Cesselli D, Rota M, Nascimbene A, De Angelis A, Hosoda T, Bearzi C, Boni A, Bolli R, Kajstura J, Anversa P, Leri A. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA. 2006;103:9226-9231. doi:10.1073/pnas.0600635103.
112. Sukhacheva TV, Chudinovskikh YA, Eremeeva MV, Serov RA, Samsonova MV, Chernyaev AL, Kim AI, Bockeria LA. Resident cardiomyocyte precursor stem cells in the myocardium of infants of the first two years of life with tetralogy of Fallot. Bull Exp Biol Med. 2012;154:158-162.
113. Steele A, Boucek RJ Jr, Jacobs JP, Steele P, Asante-Korang A, Chamizo W, Steele J, Chai PJ, Quintessenza JA. Heart cells with regenerative potential from pediatric patients with end stage heart failure: a translatable method to enrich and propagate. Stem Cells Int. 2012;2012:452102. doi:10.1155/2012/452102.
114. Mishra R, Vijayan K, Colletti EJ, Harrington DA, Matthiesen TS, Simpson D, Goh SK, Walker BL, Almeida-Porada G, Wang D, Backer CL, Dudley SC Jr, Wold LE, Kaushal S. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation. 2011;123:364-373. doi:10.1161/CIRCULATIONAHA.110.971622.
115. Simpson DL, Mishra R, Sharma S, Goh SK, Deshmukh S, Kaushal S. A strong regenerative ability of cardiac stem cells derived from neonatal hearts. Circulation. 2012;126:S46-S53. doi:10.1161/CIRCULATIONAHA.111.084699.
116. Castaldo C, Di Meglio F, Nurzynska D, Romano G, Maiello C, Bancone C, Müller P, Böhm M, Cotrufo M, Montagnani S. CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells. 2008;26:1723-1731. doi:10.1634/stemcells.2007-0732.
117. Di Meglio F, Castaldo C, Nurzynska D, Romano V, Miraglia R, Bancone C, Langella G, Vosa C, Montagnani S. Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart. J Mol Cell Cardiol. 2010;49:719-727. doi:10.1016/j.yjmcc.2010.05.013.
118. Nurzynska D, Di Meglio F, Romano V, Miraglia R, Sacco AM, Latino F, Bancone C, Della Corte A, Maiello C, Amarelli C, Montagnani S, Castaldo C. Cardiac primitive cells become committed to a cardiac fate in adult human heart with chronic ischemic disease but fail to acquire mature phenotype: genetic and phenotypic study. Basic Res Cardiol. 2013;108:320. doi:10.1007/s00395-012-0320-2.
119. Itzhaki-Alfia A, Leor J, Raanani E, Sternik L, Spiegelstein D, Netser S, Holbova R, Pevsner-Fischer M, Lavee J, Barbash IM. Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation. 2009;120:2559-2566. doi:10.1161/CIRCULATIONAHA.109.849588.
120. Torella D, Ellison GM, Karakikes I, Nadal-Ginard B. Resident cardiac stem cells. Cell Mol Life Sci. 2007;64:661-673. doi:10.1007/s00018-007-6519-y.
121. Hu S, Yan G, He W, Liu Z, Xu H, Ma G. The influence of disease and age on human cardiac stem cells. Ann Clin Biochem. 2014;51:582-590. doi:10.1177/0004563213511065.
122. Mohsin S, Khan M, Toko H, et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol. 2012;60:1278-1287. doi:10.1016/j.jacc.2012.04.047.
123. Mohsin S, Khan M, Nguyen J, Alkatib M, Siddiqi S, Hariharan N, Wallach K, Monsanto M, Gude N, Dembitsky W, Sussman MA. Rejuvenation of human cardiac progenitor cells with Pim-1 kinase. Circ Res. 2013;113:1169-1179. doi:10.1161/CIRCRESAHA.113.302302.
124. He JQ, Vu DM, Hunt G, Chugh A, Bhatnagar A, Bolli R. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One. 2011;6:e27719. doi:10.1371/journal.pone.0027719.
125. Cai C, Teng L, Vu D, He JQ, Guo Y, Li Q, Tang XL, Rokosh G, Bhatnagar A, Bolli R. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signalregulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem. 2012;287:33720-33732. doi:10.1074/jbc.M112.385542.
126. Choi SH, Jung SY, Suh W, Baek SH, Kwon SM. Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy. Transplant Proc. 2013;45:420-426. doi:10.1016/j.transproceed.2012.08.017.
127. Choi SH, Jung SY, Yoo SM, Asahara T, Suh W, Kwon SM, Baek SH. Amine-enriched surface modification facilitates expansion, attachment, and maintenance of human cardiac-derived c-kit positive progenitor cells. Int J Cardiol. 2013;168:100-107. doi:10.1016/j.ijcard.2012.09.065.
128. Choi SH, Jung SY, Yoo SY, Yoo SM, Kim da Y, Kang S, Baek SH, Kwon SM. Regulation of ROS-independent ERK signaling rescues replicative cellular senescence in ex vivo expanded human c-kit-positive cardiac progenitor cells. Int J Cardiol. 2013;169:73-82. doi:10.1016/j. ijcard.2013.08.076.
129. Kryukov O, Ruvinov E, Cohen S. Three-dimensional perfusion cultivation of human cardiac-derived progenitors facilitates their expansion while maintaining progenitor state. Tissue Eng Part C Methods. 2014;20:886-894. doi:10.1089/ten.TEC.2013.0528.
130. Fransioli J, Bailey B, Gude NA, Cottage CT, Muraski JA, Emmanuel G, Wu W, Alvarez R, Rubio M, Ottolenghi S, Schaefer E, Sussman MA. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells. 2008;26:1315-1324. doi:10.1634/stemcells.2007-0751.
131. Fischer KM, Cottage CT, Wu W, Din S, Gude NA, Avitabile D, Quijada P, Collins BL, Fransioli J, Sussman MA. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation. 2009;120:2077-2087. doi:10.1161/CIRCULATIONAHA.109.884403.
132. Zhang J, Huang C, Wu P, Yang J, Song T, Chen Y, Fan X, Wang T. Differentiation induction of cardiac c-kit positive cells from rat heart into sinus node-like cells by 5-azacytidine. Tissue Cell. 2011;43:67-74. doi:10.1016/j.tice.2010.11.005.
133. Kurazumi H, Kubo M, Ohshima M, Yamamoto Y, Takemoto Y, Suzuki R, Ikenaga S, Mikamo A, Udo K, Hamano K, Li TS. The effects of mechanical stress on the growth, differentiation, and paracrine factor production of cardiac stem cells. PLoS One. 2011;6:e28890. doi:10.1371/journal.pone.0028890.
134. Seshadri G, Che PL, Boopathy AV, Davis ME. Characterization of superoxide dismutases in cardiac progenitor cells demonstrates a critical role for manganese superoxide dismutase. Stem Cells Dev. 2012;21:3136-3146. doi:10.1089/scd.2012.0191.
135. Wang Y, Luther K. Genetically manipulated progenitor/stem cells restore function to the infarcted heart via the SDF-1α/CXCR4 signaling pathway. Prog Mol Biol Transl Sci. 2012;111:265-284. doi:10.1016/B978-0-12-398459-3.00012-5.
136. Di Felice V, Zummo G. Stem cell populations in the heart and the role of Isl1 positive cells. Eur J Histochem. 2013;57:e14. doi:10.4081/ejh.2013. e14.
137. Konstandin MH, Toko H, Gastelum GM, Quijada P, De La Torre A, Quintana M, Collins B, Din S, Avitabile D, Völkers M, Gude N, Fässler R, Sussman MA. Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circ Res. 2013;113:115-125. doi:10.1161/CIRCRESAHA.113.301152.
138. Saravanakumar M, Devaraj H. Distribution and homing pattern of c-kit+ Sca-1+ CXCR4+ resident cardiac stem cells in neonatal, postnatal, and adult mouse heart. Cardiovasc Pathol. 2013;22:257-263. doi:10.1016/j. carpath.2012.11.002.
139. Chen Z, Pan X, Yao Y, Yan F, Chen L, Huang R, Ma G. Regulation of c-kit+ progenitor cells by stromal cell derived factor-1α in adult murine heart. Heart Lung Circ. 2014;23:75-81. doi:10.1016/j.hlc.2013.05.652.
140. Xiao J, Li J, Xu T, Lv D, Shen B, Song Y, Xu J. Pregnancy-induced physiological hypertrophy protects against cardiac ischemia-reperfusion injury. Int J Clin Exp Pathol. 2014;7:229-235.
141. Xiao J, Xu T, Li J, Lv D, Chen P, Zhou Q, Xu J. Exercise-induced physiological hypertrophy initiates activation of cardiac progenitor cells. Int J Clin Exp Pathol. 2014;7:663-669.
142. Feng X, Reini SA, Richards E, Wood CE, Keller-Wood M. Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors. Am J Physiol Regul Integr Comp Physiol. 2013;305:R343-R350. doi:10.1152/ajpregu.00112.2013.
143. Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, et al. Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res. 2010;107:429-441. doi:10.1161/CIRCRESAHA.110.218487.
144. Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505:327-334. doi:10.1038/nature12984.
145. Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19-33. doi:10.1038/nrm3721.
146. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E. Defining the epithelial stem cell niche in skin. Science. 2004;303:359-363. doi:10.1126/science.1092436.
147. Scoville DH, Sato T, He XC, Li L. Current view: intestinal stem cells and signaling. Gastroenterology. 2008;134:849-864. doi:10.1053/j. gastro.2008.01.079.
148. Kechad A, Jolicoeur C, Tufford A, Mattar P, Chow RW, Harris WA, Cayouette M. Numb is required for the production of terminal asymmetric cell divisions in the developing mouse retina. J Neurosci. 2012;32:17197-17210. doi:10.1523/JNEUROSCI.4127-12.2012.
149. Houser SR, Molkentin JD. Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal. 2008;1:pe31. doi:10.1126/scisignal.125pe31.
150. Ferreira-Martins J, Rondon-Clavo C, Tugal D, et al. Spontaneous calcium oscillations regulate human cardiac progenitor cell growth. Circ Res. 2009;105:764-774. doi:10.1161/CIRCRESAHA.109.206698.
151. Kapur N, Mignery GA, Banach K. Cell cycle-dependent calcium oscillations in mouse embryonic stem cells. Am J Physiol Cell Physiol. 2007;292:C1510-C1518. doi:10.1152/ajpcell.00181.2006.
152. Kawano S, Otsu K, Kuruma A, Shoji S, Yanagida E, Muto Y, Yoshikawa F, Hirayama Y, Mikoshiba K, Furuichi T. ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium. 2006;39:313-324. doi:10.1016/j. ceca.2005.11.008.
153. Gao H, Wang F, Wang W, Makarewich CA, Zhang H, Kubo H, Berretta RM, Barr LA, Molkentin JD, Houser SR. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. J Mol Cell Cardiol. 2012;53:657-667. doi:10.1016/j.yjmcc.2012.08.005.
154. 2+ channel activity induces hypertrophy and heart failure in mice. J Clin Invest. 2012;122:280-290. doi:10.1172/JCI58227.
155. 2+ channels regulate the exit of cardiac myocytes from the cell cycle after birth. J Mol Cell Cardiol. 2013;62:122-130. doi:10.1016/j. yjmcc.2013.05.016.
156. Tillmanns J, Rota M, Hosoda T, et al. Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci USA. 2008;105:1668-1673. doi:10.1073/pnas.0706315105.
157. Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A, Jneid H, Rota M, Leri A, Kajstura J. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013;128:122-131. doi:10.1161/CIRCULATIONAHA.112.001075.
158. Sundararaman B, Avitabile D, Konstandin MH, Cottage CT, Gude N, Sussman MA. Asymmetric chromatid segregation in cardiac progenitor cells is enhanced by Pim-1 kinase. Circ Res. 2012;110:1169-1173. doi:10.1161/CIRCRESAHA.112.267716.
159. Dey D, Han L, Bauer M, Sanada F, Oikonomopoulos A, Hosoda T, Unno K, De Almeida P, Leri A, Wu JC. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res. 2013;112:1253-1262. doi:10.1161/CIRCRESAHA.112.300779.
160. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, Middleton RC, Marbán E, Molkentin JD. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509:337-341. doi:10.1038/nature13309.
161. Morrisey EE. Rewind to recover: dedifferentiation after cardiac injury. Cell Stem Cell. 2011;9:387-388. doi:10.1016/j.stem.2011.10.011.